|
| |
Image Results
Loading...
Loading...
HEPARIN Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
Heparin - Wikipedia, the free encyclopedia
Heparin, a highly-sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known ...
http://en.wikipedia.org/wiki/Heparin...
|
Heparin Injection: MedlinePlus Drug Information
Features information about dosage, usage, warnings, and side effects.
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682826.htm...
|
Information on Heparin
The U.S. Food and Drug Administration (FDA) is alerting healthcare providers of a change to the United States Pharmacopeia (USP) monograph for heparin, ...
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInfo...
|
Low molecular weight heparin - Wikipedia, the free encyclopedia
In medicine, low-molecular-weight heparin (LMWH) is a class of medication used as an anticoagulant in diseases that feature thrombosis, as well as for ...
http://en.wikipedia.org/wiki/Low_molecular_weight_heparin...
|
Heparin Sodium Injection
Heparin Information. New USP Standards for Heparin – Customer Letter – October 1 , 2009; Heparin Contamination Information – 2008 ...
http://www.baxter.com/products/biopharmaceuticals/heparin.ht...
|
Heparin-induced thrombocytopenia - Wikipedia, the free encyclopedia
Heparin-induced thrombocytopenia (HIT) is the development of thrombocytopenia (a low platelet count), due to the administration of various forms of heparin, ...
http://en.wikipedia.org/wiki/Heparin-induced_thrombocytopeni...
|
Low-Molecular-Weight Heparin in Preventing and Treating DVT ...
15 Mar 1999 ... Low-molecular-weight heparin is a relatively recent addition to the list of therapies for prophylaxis and treatment of deep venous ...
http://www.aafp.org/afp/990315ap/1607.html...
|
Information on Adverse Event Reports and Heparin
1 Jul 2009 ... The chart below shows numbers of deaths reported after heparin administration that occurred and were submitted to FDA from January 1, ...
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInfo...
|
Heparin Recall
28 Jan 2008 ... Nine lots of the antithrombin have been recalled because of a higher-than- expected rate of allergic reactions.
http://www.medscape.com/viewarticle/569325...
|
Heparin: Change in Reference Standard
1 Oct 2009 ... The change will result in 10% reduction in the potency of the heparin marketed in the US and may have clinical significance in some ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyA...
|
|